Biofrontera Inc. (BFRI)
NASDAQ: BFRI · IEX Real-Time Price · USD
1.590
-0.120 (-7.02%)
Apr 26, 2024, 4:00 PM EDT - Market closed

Biofrontera Revenue

In the year 2023, Biofrontera had annual revenue of $34.07M with 18.82% growth. Revenue in the quarter ending December 31, 2023 was $10.60M with 4.46% year-over-year growth.

Revenue (ttm)
$34.07M
Revenue Growth
+18.82%
P/S Ratio
0.24
Revenue / Employee
$410,494
Employees
83
Market Cap
8.09M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202334.07M5.40M18.82%
Dec 31, 202228.67M4.57M18.98%
Dec 31, 202124.10M5.25M27.86%
Dec 31, 202018.85M-7.33M-28.01%
Dec 31, 201926.18M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Molecular Templates 57.31M
Cosmos Health 49.59M
Universe Pharmaceuticals INC 32.31M
Precipio 15.20M
Vaccinex 570.00K
Notable Labs 310.00K
BioRestorative Therapies 145.80K
Kazia Therapeutics 15.65K
Revenue Rankings